Fluorescence Guided Surgery in Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

January 31, 2017

Study Completion Date

February 28, 2017

Conditions
Breast Cancer
Interventions
DRUG

Bevacizumab-800CW

three days prior to surgery bevacizumab-800CW will be administered

Trial Locations (1)

9713 GZ

University Medical Center Groningen, Groningen

All Listed Sponsors
collaborator

Martini Hospital Groningen

OTHER

lead

University Medical Center Groningen

OTHER

NCT02583568 - Fluorescence Guided Surgery in Breast Cancer | Biotech Hunter | Biotech Hunter